SP is sad, Mr Market quite depressed at the moment. I personally don't hold any grudges/fears, despite sitting on a respectable paper loss at the moment.
Directors are 100% motivated to get Ropren on the market and make big sales. Massive spanner was thrown into the works by Opes Prime which has set us back SP wise, but our end of FY revenues shouldn't be affected too much because we should sell all the Ropren we have by then anyway.
SO I don't know when we'll get a price or when the first sale of Ropren in Russia will happen. Could be two months, could be after christmas, in fact I'm expecting January/February to not get my hopes up. But you can bet your boots the directors are more motivated to make it happen than we will ever be. Just a matter of getting it right. Getting the company's tax structure right, the price right and yes their shares back. After all, that's their real motivation to bring in the bucks.
There have been many obstacles to overcome and a few more probably. I'll be very happy to hold over the next year at least to see what develops. If they haven't sold Ropren in Russia by end of this FY then I'll start worrying.
SLA Price at posting:
31.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)